Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.G Ambrosini, P. Marsilio, G Bruscagnin et al.|Journal of Clinical Oncology|1988Cited by 168
Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and CyclophosphamidePaola Papaldo, F. Calabresi, Massimo Lopez et al.|Journal of Clinical Oncology|2005Cited by 96
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9J. H. M. Schellens, A-R Hanauske, P Dombernowsky et al.|Anti-Cancer Drugs|2001Cited by 13